Clinical Trial Update: QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial update for QR052107B tablets in subacute cough. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subacute Cough

Drugs mentioned

• QR052107B Tablets (QR052107B)

Snippet

Sponsor: Wuhan Createrna Science and Technology Co., Ltd | Conditions: Cough | Phase 2 | Status: COMPLETED